A randomized comparison of rectal misoprostol with syntometrine on blood loss in the third stage of labour
- PMID: 20043525
A randomized comparison of rectal misoprostol with syntometrine on blood loss in the third stage of labour
Abstract
Objectives: a) To compare the clinical effect of rectal misoprostol with intramuscular syntometrine in reducing blood loss in the third stage of labour b) to determine the severity and incidence of side effects of both drugs and c) to measure blood loss, patient tolerance and acceptance of rectal misoprostol.
Methods: One hundred and forty parturients were randomly allocated to receive intramuscular syntometrine (syntocinon 10 IU + ergometrine 0.5 mg) or rectal misoprostol 400 microg within five minutes of the delivery of the anterior shoulder Blood loss was measured by the use of a plastic collection drape. Additional oxytocic therapy was instituted for uterine atony or if blood loss was in excess of one litre.
Results: There was no significant difference in patient demographics of each treatment group (Table 1). There was no difference in mean duration of the third stage of labour (8.4 +/- 14 min vs 7.8 +/- 6.6 min). The mean blood loss from those parturients receiving misoprostol (180.1 +/- 120 mls) was not significantly different (p = 0.5) from those receiving syntometrine (197 +/- 176.97 mls) for the active management of the third stage of labour Treatment with syntometrine was associated with a significant elevation of post-partum systolic blood pressure compared with misoprostol treatment (mean increase 0.57 +/- 18.79 mmHg vs -1.43 +/- 14.17 mmHg, (mean +/- SD), p < 0.04). Rectal misoprostol was well tolerated in 88.5% of participants, 11.4% reported that insertion was uncomfortable, of which 2.8% reported that they would have preferred parenteral drug administration.
Conclusion: The clinical effect of rectal misoprostol and intramuscular syntometrine were not different at the doses used in the active management of the third stage of labour in this study. Rectal misoprostol was well tolerated by the patients and had a low side effect profile. Blood loss assessment using the blood collection drape is of invaluable benefit in resource-poor settings.
Similar articles
-
Randomized comparison of rectal misoprostol with Syntometrine for management of third stage of labor.Acta Obstet Gynecol Scand. 1998 Feb;77(2):178-81. Acta Obstet Gynecol Scand. 1998. PMID: 9512323 Clinical Trial.
-
A double-blind randomized controlled trial of oral misoprostol and intramuscular syntometrine in the management of the third stage of labor.Gynecol Obstet Invest. 2007;63(1):55-60. doi: 10.1159/000095498. Epub 2006 Aug 29. Gynecol Obstet Invest. 2007. PMID: 16940738 Clinical Trial.
-
A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor.Acta Obstet Gynecol Scand. 2004 Jul;83(7):647-50. doi: 10.1111/j.0001-6349.2004.00572.x. Acta Obstet Gynecol Scand. 2004. PMID: 15225189 Clinical Trial.
-
The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor.Online J Curr Clin Trials. 1993 Aug 13;Doc No 83:[2305 words; 32 paragraphs]. Online J Curr Clin Trials. 1993. PMID: 8306013 Review.
-
Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage.J Obstet Gynaecol Can. 2009 Oct;31(10):980-993. doi: 10.1016/S1701-2163(16)34329-8. J Obstet Gynaecol Can. 2009. PMID: 19941729 Review.
Cited by
-
Prostaglandins for preventing postpartum haemorrhage.Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD000494. doi: 10.1002/14651858.CD000494.pub4. Cochrane Database Syst Rev. 2012. PMID: 22895917 Free PMC article.
-
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.Cochrane Database Syst Rev. 2018 Dec 19;12(12):CD011689. doi: 10.1002/14651858.CD011689.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2025 Apr 16;4:CD011689. doi: 10.1002/14651858.CD011689.pub4. PMID: 30569545 Free PMC article. Updated.
-
Care technologies to prevent and control hemorrhage in the third stage of labor: a systematic review.Rev Lat Am Enfermagem. 2019 Aug 19;27:e3165. doi: 10.1590/1518-8345.2761.3165. Rev Lat Am Enfermagem. 2019. PMID: 31432919 Free PMC article.
-
Postpartum misoprostol for preventing maternal mortality and morbidity.Cochrane Database Syst Rev. 2013 Jul 15;2013(7):CD008982. doi: 10.1002/14651858.CD008982.pub2. Cochrane Database Syst Rev. 2013. PMID: 23857523 Free PMC article.
-
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.Cochrane Database Syst Rev. 2025 Apr 16;4(4):CD011689. doi: 10.1002/14651858.CD011689.pub4. Cochrane Database Syst Rev. 2025. PMID: 40237648 Free PMC article.